UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (1), p.132-143

2011

Volltextzugriff (PDF)

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2008-09, Vol.48 (3), p.750-758

2008

Volltextzugriff (PDF)

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1726-1737

2014

Volltextzugriff (PDF)

No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B

Hepatology (Baltimore, Md.), 2014-02, Vol.59 (2), p.434-442

2014

Volltextzugriff (PDF)

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Gastroenterology (New York, N.Y. 1943), 2006-12, Vol.131 (6), p.1743-1751

2006

Volltextzugriff (PDF)

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Frontiers in cellular and infection microbiology, 2021-03, Vol.11, p.642358-642358

2021

Volltextzugriff (PDF)

Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection

Gastroenterology (New York, N.Y. 1943), 2010-10, Vol.139 (4), p.1207-1217.e3

2010

Volltextzugriff (PDF)

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

Hepatology (Baltimore, Md.), 2011-03, Vol.53 (3), p.763-773

2011

Volltextzugriff (PDF)

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

Retrovirology, 2009-05, Vol.6 (44), p.44-44, Article 44

2009

Volltextzugriff (PDF)

SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-CoV-2 Omicron variant and treated with pomotrelvir

Microbiology spectrum, 2024-02, Vol.12 (2), p.e0298023-e0298023

2024

Volltextzugriff (PDF)

Cyclophilin Inhibitors Reduce Phosphorylation of RNA-Dependent Protein Kinase to Restore Expression of IFN-Stimulated Genes in HCV-Infected Cells

Gastroenterology (New York, N.Y. 1943), 2014-08, Vol.147 (2), p.463-472

2014

Volltextzugriff (PDF)

Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results

Liver transplantation, 2007-03, Vol.13 (3), p.349-360

2007

Volltextzugriff (PDF)

Hepatitis B Virus Containing the I233V Mutation in the Polymerase Reverse-Transcriptase Domain Remains Sensitive to Inhibition by Adefovir

The Journal of infectious diseases, 2007-11, Vol.196 (10), p.1483-1486

2007

Volltextzugriff (PDF)

Low-Level Persistence of Drug Resistance Mutations in Hepatitis B Virus-Infected Subjects with a Past History of Lamivudine Treatment

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.343-349

2013

Volltextzugriff (PDF)

The YMDD and rtA194T Mutations Result in Decreased Replication Capacity in Wild-Type HBV as well as in HBV with Precore and Basal Core Promoter Mutations

Antiviral chemistry & chemotherapy, 2011-10, Vol.22 (1), p.13-22

2011

Volltextzugriff (PDF)

A Comparison of the Phenotypic Susceptibility Profiles of Emtricitabine and Lamivudine

Antiviral chemistry & chemotherapy, 2007-10, Vol.18 (5), p.297-300

2007

Volltextzugriff (PDF)

In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2004-11, Vol.48 (11), p.4387-4394

2004

Volltextzugriff (PDF)

Anti-Hepatitis B Virus Activity in Vitro of Combinations of Tenofovir with Nucleoside/nucleotide Analogues

Antiviral chemistry & chemotherapy, 2009-02, Vol.19 (4), p.165-176

2009

Volltextzugriff (PDF)

In Vitro Drug Susceptibility Analysis of Hepatitis B Virus Clinical Quasispecies Populations

Journal of Clinical Microbiology, 2007-10, Vol.45 (10), p.3335-3341

2007

Volltextzugriff (PDF)

SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [ 14 C]SCY-078 in Albino and Pigmented Rats

Antimicrobial agents and chemotherapy, 2019-02, Vol.63 (2)

2019

Volltextzugriff (PDF)

Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients

Antiviral therapy, 2009-01, Vol.14 (2), p.231-239

2009

Volltextzugriff (PDF)

MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples

Journal of Clinical Microbiology, 2006-11, Vol.44 (11), p.4237-4241

2006

Volltextzugriff (PDF)

SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(48)
Microbiology
(29)
Biological And Medical Sciences
(28)
Pharmacology & Pharmacy
(24)
Medical Sciences
(23)
Adenine - Analogs & Derivatives
(21)
Infectious Diseases
(20)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(18)
Antiviral Agents
(18)
Pharmacology. Drug Treatments
(18)
Female
(17)
Mutation
(17)
Virology
(16)
Male
(15)
Tenofovir
(14)
Viral Diseases
(14)
Adult
(13)
Hepatitis B Virus
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-CoV-2 Omicron variant and treated with pomotrelvir

Cyclophilin Inhibitors Reduce Phosphorylation of RNA-Dependent Protein Kinase to Restore Expression of IFN-Stimulated Genes in HCV-Infected Cells

Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results

Hepatitis B Virus Containing the I233V Mutation in the Polymerase Reverse-Transcriptase Domain Remains Sensitive to Inhibition by Adefovir

Low-Level Persistence of Drug Resistance Mutations in Hepatitis B Virus-Infected Subjects with a Past History of Lamivudine Treatment

The YMDD and rtA194T Mutations Result in Decreased Replication Capacity in Wild-Type HBV as well as in HBV with Precore and Basal Core Promoter Mutations

A Comparison of the Phenotypic Susceptibility Profiles of Emtricitabine and Lamivudine

In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1

Anti-Hepatitis B Virus Activity in Vitro of Combinations of Tenofovir with Nucleoside/nucleotide Analogues

In Vitro Drug Susceptibility Analysis of Hepatitis B Virus Clinical Quasispecies Populations

SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [ 14 C]SCY-078 in Albino and Pigmented Rats

Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients

MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples

SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies

Suchergebnisse filtern